Siemens Healthineers Logo
DE000SHL1006
SHL100
0PMJ.L

Siemens Healthineers

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

  • Portfolio advice for 21 y.o (200k portfolio)

    j jake V in Portfolio Tracking

    1 11

  • Healthineers will drop the Siemens name going forward

    Siemens Healthineers will pay €300 million for the three-year transition period and will then operate independently under the name Healthineers. The renaming is intended to create transparency, avoid confusion with the parent company, and reflect its successful path as an independent business. The transition should be easy, since the company has already used the Healthineers name element since 2016. » More on faz.net


  • Healthineers separates from Siemens and focuses on imaging and precision therapy

    Siemens will reduce its stake in Healthineers by 30 percentage points; the spin-off is to be approved by shareholders of both companies in 2027. Healthineers will change its name during a three-year transition period and pay €300 million for this; at the same time the board proposes a dividend of €1 per share. The diagnostics division will be spun off and renamed Olyrian Diagnostics, affecting about one in five employees; the general ultrasound business will be discontinued. The company is launching a cost program and expects revenue growth of 4–5% and earnings per share of €2.20–2.40 for the new fiscal year. » More on faz.net


  • Siemens Healthineers drops "Siemens" and prepares spin-off of lab division

    The medical-technology group intends to rename itself simply Healthineers within three years; the annual general meeting in February 2027 must still formally approve this. Siemens will reduce its stake to a minority and transfer around 30% of the shares to Siemens shareholders. The lab diagnostics division is to be gradually renamed Olyrian Diagnostics and spun off or sold. To offset the additional costs associated with the separation, Healthineers is launching the efficiency program "Transform4 Future" for 2028–2030; the outlook calls for comparable revenue growth of 4–5% and adjusted earnings per share of €2.20–2.40. » More on manager-magazin.de


  • Siemens Healthineers: one-year loss of 15.46% on investment made a year ago

    If €1,000 had been invested in Siemens Healthineers a year ago, investors would have €845.36 today, a loss of 15.46%. The stock closed on Oct. 21, 2026 at €41.71; a year earlier the price was €49.34. Market capitalization most recently €46.38 billion; calculation does not account for splits or dividends. » More on finanzen.net


  • Siemens Healthineers: analysts see Q3 quarter with €0.673 EPS and revenue of €6.78 billion

    Siemens Healthineers is expected to publish figures for the quarter ended 30 September 2026 on 5 November 2026. Ten analysts on average expect earnings per share of €0.673 (previous year: €0.520), and nine analysts see revenue rising by about 7.19% to €6.78 billion (previous year: €6.32 billion). For the recently ended fiscal year, 21 analysts forecast average earnings per share of €2.35 and 20 analysts forecast revenue of €23.57 billion. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Siemens Healthineers has already paid €1.00 in dividends. The last payout was in February.

Financials

In the last quarter, Siemens Healthineers had revenue of €6.78B and net profit of €589M
(EUR) September 2026
YoY
Revenue 6.78B 7.31%
Gross profit 2.45B 3.12%
Net profit 589M 0.17%
EBITDA 1.17B 1.92%

Fundamentals

Metric Value
Market capitalization
€49.19B
Number of shares
1.12B
52-week high/low
€47.25 - €32.82
Dividend yield
2.27%
Dividends TTM
€1.00
Beta
0.83
P/E ratio
22.20
PEG ratio
6.06
P/B ratio
2.46
P/S ratio
2.08

Company profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Name
Siemens Healthineers
CEO
Bernhard Montag
Headquarters Forchheim, bv
Germany
Website
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO
05/20/2020
Employees 74,600

Ticker symbols

Exchange Symbol
London Stock Exchange
0PMJ.L
XETRA
SHL.DE
Pnk
SEMHF
Frankfurt
SHL.F
Düsseldorf
SHL.DU
Hamburg
SHL.HM
Milan
1SHL.MI
London
0PMJ.L
SIX
SHL.SW
München
SHL.MU
Wien
SHL.VI
🍪

Parqet  uses cookies. Learn more